ADAP – Adaptimmune Therapeutics plc
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
3.04
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.07
EPS Last/This Y
EPS This/Next Y
-0.33
Price
0.56
Target Price
2.71
Analyst Recom
1.89
Performance Q
-5.97
Relative Volume
0.3
Beta
2.51
Ticker: ADAP
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | ADAP | 0.5776 | 0.03 | 0.00 | 3121 |
| 2025-01-24 | ADAP | 0.5881 | 0.03 | 0.33 | 3140 |
| 2025-01-27 | ADAP | 0.579 | 0.03 | 0.00 | 3141 |
| 2025-01-28 | ADAP | 0.5871 | 0.03 | 20.00 | 3155 |
| 2025-01-29 | ADAP | 0.5842 | 0.04 | 0.00 | 3176 |
| 2025-01-30 | ADAP | 0.6183 | 0.04 | 0.00 | 3181 |
| 2025-01-31 | ADAP | 0.5921 | 0.03 | 0.00 | 3305 |
| 2025-02-03 | ADAP | 0.587 | 0.03 | 0.00 | 3347 |
| 2025-02-04 | ADAP | 0.5748 | 0.03 | 0.00 | 3984 |
| 2025-02-05 | ADAP | 0.5876 | 0.03 | 0.10 | 3994 |
| 2025-02-06 | ADAP | 0.6049 | 0.03 | 0.00 | 4037 |
| 2025-02-07 | ADAP | 0.6195 | 0.03 | 999.99 | 4047 |
| 2025-02-10 | ADAP | 0.5991 | 0.03 | 999.99 | 4047 |
| 2025-02-11 | ADAP | 0.5681 | 0.04 | 999.99 | 4102 |
| 2025-02-12 | ADAP | 0.5789 | 0.06 | 999.99 | 4153 |
| 2025-02-13 | ADAP | 0.5755 | 0.07 | 3.13 | 4202 |
| 2025-02-14 | ADAP | 0.578 | 0.08 | 0.00 | 4268 |
| 2025-02-18 | ADAP | 0.5815 | 0.08 | 5.00 | 4268 |
| 2025-02-19 | ADAP | 0.5685 | 0.09 | 0.00 | 4331 |
| 2025-02-20 | ADAP | 0.578 | 0.09 | 0.00 | 4332 |
| 2025-02-21 | ADAP | 0.56 | 0.09 | 0.00 | 4569 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-01-24 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-01-27 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-01-28 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-01-29 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-01-30 | ADAP | 0.61 | 35.8 | - | -0.14 |
| 2025-01-31 | ADAP | 0.60 | 35.8 | - | -0.14 |
| 2025-02-03 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-02-04 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-05 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-02-06 | ADAP | 0.61 | 35.8 | - | -0.14 |
| 2025-02-07 | ADAP | 0.62 | 35.8 | - | -0.14 |
| 2025-02-10 | ADAP | 0.60 | 35.8 | - | -0.14 |
| 2025-02-11 | ADAP | 0.57 | 35.8 | - | -0.14 |
| 2025-02-12 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-13 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-14 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-18 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-19 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-20 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2025-02-21 | ADAP | 0.56 | 35.8 | - | -0.14 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | ADAP | -0.61 | -40.06 | 2.43 |
| 2025-01-24 | ADAP | -0.61 | -40.06 | 2.43 |
| 2025-01-27 | ADAP | -0.61 | -40.11 | 2.43 |
| 2025-01-28 | ADAP | -0.61 | -40.11 | 2.54 |
| 2025-01-29 | ADAP | -0.61 | -40.11 | 2.54 |
| 2025-01-30 | ADAP | -0.61 | -40.11 | 2.54 |
| 2025-01-31 | ADAP | -0.61 | -40.11 | 2.54 |
| 2025-02-03 | ADAP | -0.61 | -40.09 | 2.54 |
| 2025-02-04 | ADAP | -0.61 | -40.09 | 2.54 |
| 2025-02-05 | ADAP | -0.61 | -40.09 | 2.54 |
| 2025-02-06 | ADAP | -0.61 | -40.09 | 2.54 |
| 2025-02-07 | ADAP | -0.61 | -40.09 | 2.54 |
| 2025-02-10 | ADAP | -0.61 | -46.22 | 2.54 |
| 2025-02-11 | ADAP | -0.61 | -46.22 | 2.54 |
| 2025-02-12 | ADAP | -0.61 | -46.22 | 3.04 |
| 2025-02-13 | ADAP | -0.61 | -46.22 | 3.04 |
| 2025-02-14 | ADAP | -0.61 | -46.22 | 3.04 |
| 2025-02-18 | ADAP | -0.61 | -46.22 | 3.04 |
| 2025-02-19 | ADAP | -0.61 | -46.22 | 3.04 |
| 2025-02-20 | ADAP | -0.61 | -46.22 | 3.04 |
| 2025-02-21 | ADAP | -0.61 | -46.22 | 3.04 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
-0.15
Avg. EPS Est. Next Quarter
Insider Transactions
-0.61
Institutional Transactions
-46.22
Beta
2.51
Average Sales Estimate Current Quarter
8
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
15
Growth Score
39
Sentiment Score
5
Actual DrawDown %
95.8
Max Drawdown 5-Year %
-96.5
Target Price
2.71
P/E
Forward P/E
PEG
P/S
0.82
P/B
1.79
P/Free Cash Flow
EPS
-0.21
Average EPS Est. Cur. Y
-0.14
EPS Next Y. (Est.)
-0.47
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-25.63
Relative Volume
0.3
Return on Equity vs Sector %
-74.9
Return on Equity vs Industry %
-59.3
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.15
EBIT Estimation
stock quote shares ADAP – Adaptimmune Therapeutics plc Stock Price stock today
news today ADAP – Adaptimmune Therapeutics plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADAP – Adaptimmune Therapeutics plc yahoo finance google finance
stock history ADAP – Adaptimmune Therapeutics plc invest stock market
stock prices ADAP premarket after hours
ticker ADAP fair value insiders trading